Can a puff of oxygen during exercise ease breathlessness for IPF patients?
NCT ID NCT03688334
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study looked at whether giving extra oxygen (40%) during exercise helps people with idiopathic pulmonary fibrosis (IPF) who do not have low oxygen at rest but do get low oxygen when active. Fifteen stable IPF patients completed exercise tests while breathing either oxygen or medical air (sham). The researchers measured exercise duration, breathlessness, fatigue, and oxygen levels in the brain and muscles.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- oxygen supplementation (40%)
- What this could lead to
- If it works, this could show that using oxygen during exercise helps people with IPF feel less breathless and exercise longer.
- What could go wrong
- This is a very small, early study with only 15 people. The results may not apply to all IPF patients, and the benefit may be small or not meaningful.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
"G. Papanikolaou" General Hospital
Thessaloniki, 57010, Greece
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill slow lung scarring in IPF?
- Beyond the lungs: the hidden emotional toll of IPF medications
- Can umbilical cord stem cells ease a scarring lung disease?
- Spotting hidden blood clots in scarred lungs: a study hunts for clues
- What makes someone stop a lung fibrosis drug? a study asks patients directly
- A smarter way to track lung disease? new platform aims to personalize COPD and IPF care